EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension

Grzegorz Grześk iD, Adrianna Witczyńska, Magdalena Węglarz, Łukasz Wołowiec iD, Jacek Nowaczyk iD, Elżbieta Grześk, Alicja Nowaczyk iD

Molecules · 2023

DOI: 10.3390/molecules28020861 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Grzegorz Grześk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Colle-gium Medicum in Bydgoszcz, Nicolaus Copernicus …. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Heart Failure. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endogenous nitric oxide (NO)-dependent vascular relaxation plays a leading role in the homeostasis of the cardiovascular, pulmonary, and vascular systems and organs, such as the kidneys, brain, and liver. The mechanism of the intracellular action of NO in blood vessels involves the stimulation of the activity of the soluble cytosolic form of guanylyl cyclase (soluble guanylyl cyclase, sGC), increasing the level of cyclic 3′-5′—guanosine monophosphate (cGMP) in smooth muscle and subsequent vasodilation. In recent years, a new group of drugs, soluble guanylyl cyclase stimulators, has found its way into clinical practice. Based on the CHEST-1 and PATENT-1 trials, riociguat was introduced into clinical practice for treating chronic thromboembolic pulmonary hypertension (CTEPH). In January 2021, the FDA approved the use of another drug, vericiguat, for the treatment of heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryHeart FailureHumansSoluble Guanylyl CyclaseGuanylate CyclaseLungCyclic GMPNitric Oxide

Stichwörter der Autor:innen

chronic heart failure (CHF)guanylate cyclase (GC)pulmonary arterial hypertension (PAH)riociguatvericiguat

Substanzen

Soluble Guanylyl CyclaseGuanylate CyclaseCyclic GMPNitric Oxide

Autor:innen und Institutionen

  • Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Colle-gium Medicum in Bydgoszcz, Nicolaus Copernicus University, 75 Ujejskiego St., 85-168 Bydgoszcz, Poland.
  • Department of Organic Chemistry, Faculty of Pharmacy, Ludwik Rydygier Collegium Medicum in Byd-goszcz, Nicolaus Copernicus University in Toruń, 2 dr. A. Jurasza St., 85-094 Bydgoszcz, Poland.
  • Physical Chemistry and Chemistry of Polymers, Faculty of Chemistry, Nicolaus Copernicus University, 7 Gagarina St., 87-100 Toruń, Poland.
  • Department of Pediatrics, Hematology and Oncology, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 9 Skłodowskiej-Curie St., 85-094 Bydgoszcz, Poland.

ORCID-Profile: Grzegorz Grześk, Łukasz Wołowiec, Jacek Nowaczyk, Alicja Nowaczyk

Zitieren

APA

Grześk, G., Witczyńska, A., Węglarz, M., Wołowiec, Ł., Nowaczyk, J., Grześk, E., & Nowaczyk, A. (2023). Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension. Molecules. https://doi.org/10.3390/molecules28020861

Vancouver

Grześk G, Witczyńska A, Węglarz M, Wołowiec Ł, Nowaczyk J, Grześk E, et al. Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension. Molecules. 2023. doi:10.3390/molecules28020861

BibTeX
@article{Grzek2023,
  author = {Grześk, Grzegorz and Witczyńska, Adrianna and Węglarz, Magdalena and Wołowiec, Łukasz and Nowaczyk, Jacek and Grześk, Elżbieta and Nowaczyk, Alicja},
  title = {Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28020861}
}
Kostenlos starten →